Targeted immunotherapy for pediatric solid tumors

Research output: Contribution to journalReview articlepeer-review

7 Scopus citations


ABSTRACT: Metastatic and refractory pediatric solid tumor malignancies continue to have a poor outcome despite the > 80% cure rates appreciated in many pediatric cancers. Targeted immunotherapy is impacting treatment and survival in these aggressive tumors. We review current promising immunotherapeutic approaches in the pediatric oncology solid tumor setting.

Original languageEnglish (US)
Issue number3
StatePublished - Mar 3 2016


  • Immunotherapy
  • pediatric oncology
  • solid tumors

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Oncology

Fingerprint Dive into the research topics of 'Targeted immunotherapy for pediatric solid tumors'. Together they form a unique fingerprint.

Cite this